References
- FisherC. Epithelioid Sarcoma of Enzinger. Adv. Anat. Pathol.13(3), 114–121 (2006).
- RekhiB , GoradBD , ChinoyRF. Proximal-type epithelioid sarcoma–a rare, aggressive subtype of epithelioid sarcoma presenting as a recurrent perineal mass in a middle-aged male. World J. Surg. Oncol.5, 28 (2007).
- BarwadA , DeyP , DasA. Fine needle aspiration cytology of epithelioid sarcoma. Diagn. Cytopathol.39(7), 517–520 (2011).
- YadavYK , KhannaG , RajniKaushik A. Cytomorphology of epithelioid sarcoma: a diagnostic enigma. Clin. Cancer Investig. J.1(3), 156 (2012).
- GuillouL , WaddenC , CoindreJM , KrauszT , FletcherCD. “Proximal-type” epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am. J. Surg. Pathol.21(2), 130–146 (1997).
- ThwayK , JonesRL , NoujaimJ , FisherC. Epithelioid sarcoma: diagnostic features and genetics. Adv. Anat. Pathol.23(1), 41–49 (2016).
- MiettinenM , Fanburg-SmithJC , VirolainenM , ShmooklerBM , FetschJF. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum. Pathol.30(8), 934–942 (1999).
- HornickJL , DalCin P , FletcherCDM. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am. J. Surg. Pathol.33(4), 542–550 (2009).
- HollmannTJ , HornickJL. INI1-deficient tumors: diagnostic features and molecular genetics. Am. J. Surg. Pathol.35(10), e47–63 (2011).
- JawadMU , ExteinJ , MinES , ScullySP. Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database. Clin. Orthop.467(11), 2939–2948 (2009).
- FrezzaAM , JonesRL , LoVullo Set al.Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: a multi-institutional case series. JAMA Oncol.4(9), e180219 (2018).
- GounderM , SchöffskiP , JonesRLet al.Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase II basket study. Lancet Oncol.21(11), 1423–1432 (2020).
- MooreRG , SteinhoffMM , GranaiCO , DeMarsLR. Vulvar epithelioid sarcoma in pregnancy. Gynecol. Oncol.85(1), 218–222 (2002).
- EroğluA , SarıA , ErogluN. Primary epithelioid sarcoma of the vulva in pregnancy. Gynecol. Surg.5(1), 61–64 (2008).
- CasanovaM , FerrariA , ColliniPet al.Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee. Cancer106(3), 708–717 (2006).
- GrossE , RaoBN , PappoAet al.Epithelioid sarcoma in children. J. Pediatr. Surg.31(12), 1663–1665 (1996).
- PaiKK , PaiSB , SripathiH , PranabRao P. Epithelioid sarcoma: a diagnostic challenge. Indian J. Dermatol. Venereol. Leprol.72(6), 446–448 (2006).
- SullivanLM , FolpeAL , PawelBR , JudkinsAR , BiegelJA. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod. Pathol.26(3), 385–392 (2013).
- MiettinenM , Fanburg-SmithJC , VirolainenM , ShmooklerBM , FetschJF. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum. Pathol.30(8), 934–942 (1999).
- NishibabaR , HigashiY , GotoY , HisaokaM , KanekuraT. Epithelioid sarcoma with multiple lesions on the left arm: a case report. J. Med Case Rep.10(1), 295 (2016).
- JonesR , ConstantinidouA , OlmosDet al.Role of palliative chemotherapy in advanced epithelioid sarcoma. Am. J. Clin. Oncol.35, 351–357 (2011).
- PecoraA , HalpernS , WeberMet al.Rapid and complete response to combination anti-CTLA-4 and anti-PD-1 checkpoint inhibitor therapy in a patient with stage IV refractory end-stage epithelioid sarcoma: a case report. J. Immunother.43(9), 286–290 (2020).